Malignancy: Prostate Cancer Flashcards

1
Q

Most prostate cancer cases are diagnosed after what age?

A

65

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Most prostate cancer cases occur in what ethnicity?

A

Black-african

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the presenting symptoms of advanced prostate cancer? (it is usually asymptomatic at diagnosis)

A

Urinary outflow obstruction.

Pelvic or back pain due to bone metastases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

In patients with low-risk localised prostate cancer, and those at intermediate risk who decline radical treatments, active monitoring is an option.

What does this involve?

A

Close monitoring to avoid unnecessary treatment until disease progression occurs (or until the patient requests treatment)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is androgen deprivation therapy? (2)

A

This involves the use of either a luteinising-hormone releasing hormone (LHRH) agonist (buserelin, goserelin, leuprorelin acetate, or triptorelin), OR bilateral orchidectomy - which removes the supply of the endogenous hormone. Androgen deprivation therapy may be continued for up to 3 years in patients with high-risk localised prostate cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Androgen deprivation therapy involves the use of a luteinising hormone-releasing hormone (LHRH) agonist OR a bilateral orchidectomy which removes the supply of endogenous hormone.

What are some LHRH agonists? (

A
  1. Buserelin
  2. Goserelin
  3. Leuprorelin acetate
  4. Triptorelin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the main side effects of androgen deprivation therapy?

A
  1. Urinary and sexual dysfunction
  2. Loss of fertility
  3. Radiation-induced enteropathy
  4. Hot flushes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tumour flare, due to an initial surge in testosterone concentrations can occur in the initial stages of treatment with androgen deprivation therapy. How can this be managed?

A

The prophylactic use of anti-androgen therapy such as cyproterone acetate has been used.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Can prostate cancer patients used PDEV inhibitors?

A

Yes - they should have access to specialist ED services.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Osteoporosis and fatigue can occur with androgen deprivation therapy. If a bisphosphonate it not suitable, what is an alternative?

A

Denosumab.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Gynaecomastia can occur with bicalutamide treatment of what duration?

A

Long-term, longer than 6 months.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is bilateral orchietomy?

A

Testicle removal, both.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

In the treatment of metastatic prostate cancer, bilateral orchidectomy should be offered to all patients. Understandably, this is not an appealing option for many men.

Anti-androgen monotherapy with bicalutamide can be offered to those who are willing to accept what?

A

Anti-androgen monotherapy with bicalutamide [unlicensed indication] can be offered to those who are willing to accept the adverse impact on overall survival and gynaecomastia in the hope of retaining sexual function. However, if satisfactory sexual function is not maintained, stop bicalutamide and start androgen deprivation therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

In patients who develop hormone-relapsed metastatic tumour, chemotherapy with what can be used? What length should treatment be limited to?

A

For patients who develop hormone-relapsed metastatic tumour, chemotherapy with docetaxel can be used.

It is recommended to stop the treatment with docetaxel after 10 cycles, or if severe adverse events occured.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In patients with hormone-relapsed prostate cancer, what can be offered as third line therapy, after androgen deprivation therapy and anti-androgen therapy?

A

A corticosteroid such as dexamethasone.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What can be used [unlicensed], initially for up to 10 weeks, to manage troublesome hot flushes caused by long-term androgen suppression?

A

Medroxyprogesterone acetate - cyproterone acetate is an alternative.